The Global Endoluminal Suturing Devices Market was valued at USD 81.1 million in 2025 and is estimated to grow at a CAGR of 14.1% to reach USD 290.9 million by 2035.
Rising demand for minimally invasive treatment procedures and the increasing incidence of chronic health conditions worldwide are major factors contributing to market expansion. Endoluminal suturing devices are advanced medical instruments developed to place sutures during endoscopic procedures performed through internal luminal pathways. These systems are widely utilized for tissue closure, repair, and fixation during gastrointestinal interventions, including bariatric procedures and treatments associated with digestive disorders. Growing preference for minimally invasive care among aging populations is further supporting market growth, as older adults are increasingly affected by obesity-related complications and gastrointestinal conditions that require advanced therapeutic procedures. Continuous innovation in device technology has improved tissue capture systems, full-thickness suturing performance, and compatibility with standard endoscopic platforms. These advancements have broadened the use of endoluminal suturing systems across multiple clinical applications, including defect management, hemostatic procedures, tissue approximation, and fixation procedures, while reducing the need for conventional open surgeries.
The single-use segment accounted for 53.7% share in 2025 due to increasing emphasis on patient safety, infection prevention, and standardized clinical performance. Disposable endoluminal suturing devices have become widely preferred because they help eliminate contamination risks and reduce the complexity associated with sterilization procedures. Healthcare providers are increasingly adopting these products to maintain consistent treatment quality during therapeutic endoscopic procedures. Rising awareness regarding hygiene-focused healthcare practices and stricter compliance standards has further accelerated the adoption of single-use devices across hospitals and specialty care centers.
The hospitals segment generated USD 48 million in 2025, making it the leading end-use category in the market. Hospitals continue to represent the primary setting for advanced gastrointestinal, bariatric, and therapeutic endoscopic procedures that require endoluminal suturing systems. The availability of technologically advanced endoscopy suites, highly trained multidisciplinary teams, and access to specialized patient care has strengthened product utilization across hospital environments. Increasing focus on minimally invasive treatment approaches and improved procedural efficiency has also contributed to the widespread integration of these devices into clinical workflows.
North America Endoluminal Suturing Devices Market accounted for 36.3% share in 2025. The regional market is being driven by the growing prevalence of obesity and gastrointestinal disorders, which continue to increase the demand for minimally invasive bariatric and therapeutic procedures. Strong healthcare infrastructure, rapid adoption of advanced endoscopic technologies, and the presence of experienced medical professionals have further supported market development across the region. Healthcare providers are increasingly prioritizing technologies that improve patient recovery, shorten hospital stays, and enhance treatment outcomes, which continues to strengthen demand for endoluminal suturing systems throughout North America.
Key companies operating in the Endoluminal Suturing Devices Market include Medtronic, Teleflex, Karl Storz, Ovesco, Olympus, Endo Tools Therapeutics, B. Braun, Boston Scientific, Terumo, RICHARD WOLF, Cook Group, ergosuture, LUMENDi, Johnson & Johnson, and USGI MEDICAL. Companies participating in the endoluminal suturing devices market are focusing heavily on technological innovation, strategic collaborations, and product portfolio expansion to strengthen their market position. Manufacturers are investing in advanced suturing platforms with improved tissue handling, enhanced precision, and compatibility with modern endoscopic systems to support complex minimally invasive procedures. Many companies are also expanding their presence through partnerships with hospitals, gastroenterology centers, and healthcare distributors to improve product accessibility across developed and emerging markets. In addition, businesses are emphasizing regulatory approvals, clinician training programs, and research initiatives to improve adoption rates and strengthen brand credibility. Market participants are further concentrating on single-use device development, workflow optimization, and integration with advanced endoscopic technologies to improve procedural efficiency and enhance patient outcomes across healthcare facilities.
This product will be delivered within 2-4 business days.
Rising demand for minimally invasive treatment procedures and the increasing incidence of chronic health conditions worldwide are major factors contributing to market expansion. Endoluminal suturing devices are advanced medical instruments developed to place sutures during endoscopic procedures performed through internal luminal pathways. These systems are widely utilized for tissue closure, repair, and fixation during gastrointestinal interventions, including bariatric procedures and treatments associated with digestive disorders. Growing preference for minimally invasive care among aging populations is further supporting market growth, as older adults are increasingly affected by obesity-related complications and gastrointestinal conditions that require advanced therapeutic procedures. Continuous innovation in device technology has improved tissue capture systems, full-thickness suturing performance, and compatibility with standard endoscopic platforms. These advancements have broadened the use of endoluminal suturing systems across multiple clinical applications, including defect management, hemostatic procedures, tissue approximation, and fixation procedures, while reducing the need for conventional open surgeries.
The single-use segment accounted for 53.7% share in 2025 due to increasing emphasis on patient safety, infection prevention, and standardized clinical performance. Disposable endoluminal suturing devices have become widely preferred because they help eliminate contamination risks and reduce the complexity associated with sterilization procedures. Healthcare providers are increasingly adopting these products to maintain consistent treatment quality during therapeutic endoscopic procedures. Rising awareness regarding hygiene-focused healthcare practices and stricter compliance standards has further accelerated the adoption of single-use devices across hospitals and specialty care centers.
The hospitals segment generated USD 48 million in 2025, making it the leading end-use category in the market. Hospitals continue to represent the primary setting for advanced gastrointestinal, bariatric, and therapeutic endoscopic procedures that require endoluminal suturing systems. The availability of technologically advanced endoscopy suites, highly trained multidisciplinary teams, and access to specialized patient care has strengthened product utilization across hospital environments. Increasing focus on minimally invasive treatment approaches and improved procedural efficiency has also contributed to the widespread integration of these devices into clinical workflows.
North America Endoluminal Suturing Devices Market accounted for 36.3% share in 2025. The regional market is being driven by the growing prevalence of obesity and gastrointestinal disorders, which continue to increase the demand for minimally invasive bariatric and therapeutic procedures. Strong healthcare infrastructure, rapid adoption of advanced endoscopic technologies, and the presence of experienced medical professionals have further supported market development across the region. Healthcare providers are increasingly prioritizing technologies that improve patient recovery, shorten hospital stays, and enhance treatment outcomes, which continues to strengthen demand for endoluminal suturing systems throughout North America.
Key companies operating in the Endoluminal Suturing Devices Market include Medtronic, Teleflex, Karl Storz, Ovesco, Olympus, Endo Tools Therapeutics, B. Braun, Boston Scientific, Terumo, RICHARD WOLF, Cook Group, ergosuture, LUMENDi, Johnson & Johnson, and USGI MEDICAL. Companies participating in the endoluminal suturing devices market are focusing heavily on technological innovation, strategic collaborations, and product portfolio expansion to strengthen their market position. Manufacturers are investing in advanced suturing platforms with improved tissue handling, enhanced precision, and compatibility with modern endoscopic systems to support complex minimally invasive procedures. Many companies are also expanding their presence through partnerships with hospitals, gastroenterology centers, and healthcare distributors to improve product accessibility across developed and emerging markets. In addition, businesses are emphasizing regulatory approvals, clinician training programs, and research initiatives to improve adoption rates and strengthen brand credibility. Market participants are further concentrating on single-use device development, workflow optimization, and integration with advanced endoscopic technologies to improve procedural efficiency and enhance patient outcomes across healthcare facilities.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product Type, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Endoluminal Suturing Devices market report include:- B. Braun
- Boston Scientific
- Cook Group
- Endo Tools Therapeutics
- ergosuture
- Johnson & Johnson
- Karl Storz
- LUMENDi
- Medtronic
- OLYMPUS
- Ovesco
- RICHARD WOLF
- Teleflex
- Terumo
- USGI MEDICAL
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | May 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 81.1 Million |
| Forecasted Market Value ( USD | $ 290.9 Million |
| Compound Annual Growth Rate | 14.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
